EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Artesunate Induces G0 / G1 Phase Arrest in Tumor Cells and Associates With Cyclin‐Dependent Kinase 4 ( CDK4 )

Xinyu Chi, Qicong Chen, Gang Wang, Honglin Luo, Shenhong Qu, Xiaosu Zou

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 04.05.2026. Verfasst von Xinyu Chi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Communicable and Severe Diseases, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: Artesunate, Cyclin-Dependent Kinase 4, G1 Phase Cell Cycle Checkpoints, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Natural Science Foundation, National Natural Science Foundation of China, Guangxi Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐small cell lung cancer ( NSCLC ) is the leading cause of cancer‐related death worldwide. Cyclin‐dependent kinase 4 ( CDK4 ) is a well‐validated oncogenic driver in NSCLC , yet current CDK4 inhibitors—predominantly based on the aminopyrimidine scaffold—are limited by structural homogeneity and the rapid emergence of acquired resistance, underscoring the need for novel chemotypes.

Methods

We employed a HuProt human proteome microarray to screen for direct cellular targets of artesunate, an FDA ‐approved artemisinin derivative. Candidate interactions were validated by molecular docking, surface plasmon resonance ( SPR ), and in vitro kinase assays. Functional effects were assessed in A549 and H1299 NSCLC cell lines using flow cytometry and Western blotting.

Results

Artesunate was identified as a direct binder of CDK4 , with molecular docking revealing a strong binding affinity (−7.069 kcal/mol). SPR analysis confirmed this interaction with a K d of 488 μM , and in vitro kinase assays demonstrated potent inhibition of CDK4 /Cyclin D3 activity ( IC 50 = 0.2943 μM ). Treatment with artesunate induced significant G0 / G1 cell cycle arrest in both A549 and H1299 cells. This effect was mediated through inhibition of the CDK4 –Rb– E2F axis, as evidenced by dose‐dependent suppression of Rb phosphorylation at Ser780 and Ser795.

Conclusion

Our findings establish artesunate as a structurally distinct, non‐aminopyrimidine CDK4 inhibitor with potent biochemical and cellular activity in NSCLC models. This work provides a promising therapeutic strategy to circumvent resistance associated with current CDK4 inhibitors and supports the repurposing of artesunate for CDK4 ‐driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtesunateCyclin-Dependent Kinase 4G1 Phase Cell Cycle CheckpointsCarcinoma, Non-Small-Cell LungLung NeoplasmsProtein Kinase InhibitorsResting Phase, Cell CycleHumansMolecular Docking SimulationCell Line, TumorCell ProliferationCyclin D3

Stichwörter der Autor:innen

CDK4artesunatecell cycle arresthuman proteome microarraylung cancer

Substanzen

ArtesunateCyclin-Dependent Kinase 4CDK4 protein, humanProtein Kinase InhibitorsCyclin D3

Autor:innen und Institutionen

  • Research Center of Communicable and Severe Diseases, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Institute of Oncology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Förderung

  • Guangxi Natural Science Foundation
  • National Natural Science Foundation of China
  • Guangxi Key Research and Development Program
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Chi, X., Chen, Q., Wang, G., Luo, H., Qu, S., & Zou, X. (2026). Artesunate Induces G0 / G1 Phase Arrest in Tumor Cells and Associates With Cyclin‐Dependent Kinase 4 ( CDK4 ). Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71907

Vancouver

Chi X, Chen Q, Wang G, Luo H, Qu S, Zou X. Artesunate Induces G0 / G1 Phase Arrest in Tumor Cells and Associates With Cyclin‐Dependent Kinase 4 ( CDK4 ). Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71907

BibTeX
@article{Chi2026,
  author = {Chi, Xinyu and Chen, Qicong and Wang, Gang and Luo, Honglin and Qu, Shenhong and Zou, Xiaosu},
  title = {Artesunate Induces G0 / G1 Phase Arrest in Tumor Cells and Associates With Cyclin‐Dependent Kinase 4 ( CDK4 )},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71907}
}
Kostenlos starten →